Boston Trust Walden Corp Sells 14,444 Shares of Agilent Technologies, Inc. $A

Boston Trust Walden Corp lessened its position in shares of Agilent Technologies, Inc. (NYSE:A) by 6.9% in the first quarter, HoldingsChannel.com reports. The fund owned 193,437 shares of the medical research company’s stock after selling 14,444 shares during the period. Boston Trust Walden Corp’s holdings in Agilent Technologies were worth $22,048,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently modified their holdings of A. Core Wealth Advisors LLC bought a new stake in shares of Agilent Technologies during the 4th quarter worth $26,000. SHP Wealth Management bought a new position in shares of Agilent Technologies in the fourth quarter worth about $26,000. Board of the Pension Protection Fund acquired a new stake in shares of Agilent Technologies in the 4th quarter valued at approximately $27,000. Navalign LLC bought a new stake in shares of Agilent Technologies during the 4th quarter valued at approximately $27,000. Finally, MV Capital Management Inc. bought a new stake in shares of Agilent Technologies during the 4th quarter valued at approximately $28,000.

Agilent Technologies Price Performance

Shares of A opened at $130.79 on Friday. Agilent Technologies, Inc. has a 1 year low of $108.35 and a 1 year high of $160.27. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62. The company has a market capitalization of $36.94 billion, a price-to-earnings ratio of 26.26, a price-to-earnings-growth ratio of 2.33 and a beta of 1.25. The business has a 50-day moving average of $124.00 and a 200-day moving average of $125.98.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, topping analysts’ consensus estimates of $1.41 by $0.08. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The company had revenue of $1.83 billion for the quarter, compared to analyst estimates of $1.80 billion. During the same period in the previous year, the firm earned $1.31 earnings per share. The firm’s quarterly revenue was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, equities research analysts anticipate that Agilent Technologies, Inc. will post 6 earnings per share for the current year.

Agilent Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th will be issued a dividend of $0.255 per share. The ex-dividend date is Tuesday, June 30th. This represents a $1.02 annualized dividend and a dividend yield of 0.8%. Agilent Technologies’s dividend payout ratio is currently 20.48%.

Analyst Ratings Changes

Several equities analysts recently commented on the stock. Barclays increased their price objective on shares of Agilent Technologies from $145.00 to $150.00 and gave the company an “overweight” rating in a research note on Wednesday, June 24th. HSBC dropped their price target on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research note on Wednesday, June 3rd. Wells Fargo & Company cut their price objective on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a report on Thursday, May 28th. Robert W. Baird boosted their price objective on Agilent Technologies from $155.00 to $156.00 and gave the stock an “outperform” rating in a research report on Tuesday, May 26th. Finally, Wolfe Research reaffirmed a “hold” rating on shares of Agilent Technologies in a report on Tuesday, June 2nd. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $160.88.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.